Affiliation:
1. Institute of Applied Health Research
University of Birmingham
United Kingdom
2. Department of Cardiology
Chinese PLA Medical School
Chinese PLA General Hospital
Beijing China
3. Service de Cardiologie
Centre Hospitalier Universitaire et Faculté de Médecine
EA7505
Université de Tours
France
4. Service d'information médicale, d’épidémiologie et d’économie de la santé
Centre Hospitalier Universitaire et Faculté de Médecine
EA7505
Université de Tours
France
5. Division of Cardiology
Department of Internal Medicine
Yonsei University Health System
Seoul Republic of Korea
6. Liverpool Centre for Cardiovascular Science
University of Liverpool and Liverpool Heart & Chest Hospital
Liverpool United Kingdom
7. Aalborg Thrombosis Research Unit
Department of Clinical Medicine
Faculty of Health
Aalborg University
Aalborg Denmark
Abstract
Background
The C
2
HEST score (coronary artery disease or chronic obstructive pulmonary disease [1 point each]; hypertension [1 point]; elderly [age ≥75 years, 2 points]; systolic heart failure [2 points]; thyroid disease [hyperthyroidism, 1 point]) was initially proposed for predicting incident atrial fibrillation (AF) in the general population. Its performance in poststroke patients remains to be established, especially because patients at high risk for incident AF should be targeted for more comprehensive screening. This study aimed to evaluate this newly established incident AF prediction risk score in a post–ischemic stroke population.
Methods and Results
Validation was based on a hospital‐based nationwide cohort with 240 459 French post–ischemic stroke patients. Kaplan–Meier curves for incident rate of AF depict differences between varying risk categories. Discrimination of the C
2
HEST score was evaluated using the C index, the net reclassification index, integrated discriminatory improvement, and decision curve analysis. During 7.9±11.5 months of follow‐up, 14 095 patients developed incident AF. The incidence of AF increased from 23.5 per 1000 patient‐years in patients with a C
2
HEST score of 0 to 196.8 per 1000 patient‐years in patients with a C
2
HEST score ≥6. Kaplan–Meier curves showed a clear difference among different risk strata (log‐rank
P
<0.0001). The C
2
HEST score had good discrimination with a C index of 0.734 (95% CI, 0.732–0.736), which was better than the Framingham risk score and the CHA
2
DS
2
‐VASc score (congestive heart failure, hypertension, age ≥75 [doubled], diabetes mellitus, stroke [doubled], vascular disease, age 65 to 74 years, and female sex) (
P
<0.0001, respectively). The C
2
HEST score was also superior to the Framingham risk score and the CHA
2
DS
2
‐VASc score as shown by the net reclassification index, integrated discriminatory improvement (
P
<0.0001, respectively) and decision curve analysis.
Conclusions
The C
2
HEST score performed well in discriminating the individual risk of developing incident AF in a white European population hospitalized with previous ischemic stroke. This simple score may potentially be used as a risk stratification tool for decision making in relation to a screening strategy for AF in post–ischemic stroke patients.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献